Download PDF
PSYCH up2date 2014; 8(06): 349-364
DOI: 10.1055/s-0034-1387360
Organische psychische Störungen
© Georg Thieme Verlag KG Stuttgart · New York

Differenzialdiagnose der Demenz

Anton Gietl
,
Egemen Savaskan
Further Information

Publication History

Publication Date:
16 October 2014 (online)

Also available at
    Permissions and Reprints All articles of this category
Kernaussagen

Für die Diagnose einer Demenz nach ICD-10 müssen die Symptome über mindestens 6 Monate bestanden haben. Alle klinisch-organischen und behandelbaren Ursachen (z. B. endokriner oder infektiöser Genese) sind bereits im Vorfeld der Diagnostik abzuklären, ebenso seltene genetische Ursachen – insbesondere, wenn es sich um eine Manifestation im relativ jungen Alter handelt. Für die weitere Differenzialdiagnostik der verschiedenen Demenzursachen empfiehlt sich ein standardisierter Untersuchungsgang, der neben einer detaillierten Anamnese (möglichst unter Befragung eines Angehörigen) eine klinische Untersuchung, Laborwerte (inkl. Biomarker), zerebrale Bildgebung und neuropsychologische Untersuchungen beinhaltet.

 

  • Literatur

  • 1 Diagnostic and Statistical Manual of Mental Disorders: DSM IV (text revision). Washington DC: American Psychiatric Association; 2000
    Google Scholar
  • 2 WHO. Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F), Klinisch-diagnostische Leitlinien. Bern: Huber; 2008
    Google Scholar
  • 3 McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 263-269
    CrossrefPubMedGoogle Scholar
  • 4 Diagnose und Behandlungsleitlinie Demenz: Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie. Berlin, Heidelberg: Springer; 2010
    Google Scholar
  • 5 Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia – meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119: 252-265
    CrossrefGoogle Scholar
  • 6 Albert MS, DeKosky ST, Dickson D et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011; 7: 270-279
    CrossrefGoogle Scholar
  • 7 Savaskan E. Delir im Alter: Ätiologie, Differenzialdiagnose und Therapie. Leading Opinions Neurologie & Psychiatrie 2012; 1: 6-7
    Google Scholar
  • 8 Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383: 911-922
    CrossrefGoogle Scholar
  • 9 Pfennig A, Littmann E, Bauer M. Neurocognitive impairment and dementia in mood disorders. J Neuropsychiatry Clin Neurosci 2007; 19: 373-382
    CrossrefGoogle Scholar
  • 10 Alexopoulos GS. Depression in the elderly. Lancet 2005; 365: 1961-1970
    CrossrefGoogle Scholar
  • 11 Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med 2003; 163: 2219-2229
    CrossrefGoogle Scholar
  • 12 Vann Jones SA, O’Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 2014; 44: 673-683
    CrossrefGoogle Scholar
  • 13 Panegyres PK, Frencham K. Course and causes of suspected dementia in young adults: a longitudinal study. Am J Alzheimers Dis Other Demen 2007; 22: 48-56
    CrossrefGoogle Scholar
  • 14 Payer J, Petrovic T, Lisy L et al. Hashimoto encephalopathy: a rare intricate syndrome. Int J Endocrinol Metab 2012; 10: 506-514
    CrossrefGoogle Scholar
  • 15 Ridley NJ, Draper B, Withall A. Alcohol-related dementia: an update of the evidence. Alzheimers Res Ther 2013; 5: 3
    CrossrefGoogle Scholar
  • 16 Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 2011; 7: 284-294
    CrossrefGoogle Scholar
  • 17 Wehling M. [Medication in the elderly: cognitive impairment by drugs]. Internist (Berl) 2012; 53: 1240-1247
    CrossrefGoogle Scholar
  • 18 Tannenbaum C, Paquette A, Hilmer S et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 2012; 29: 639-658
    Google Scholar
  • 19 Savaskan Egemen GA. Genese und Abgrenzung von Demenz zu Depression und Delir. Hausarzt Praxis 2013; 8: 24-28
    Google Scholar
  • 20 Witt K, Deuschl G, Bartsch T. [Frontotemporal dementias]. Nervenarzt 2013; 84: 20-32
    CrossrefGoogle Scholar
  • 21 Rascovsky K, Hodges JR, Knopman D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-2477
    CrossrefGoogle Scholar
  • 22 Gorno-Tempini ML, Hillis AE, Weintraub S et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014
    CrossrefGoogle Scholar
  • 23 Jellinger KA. Formation and development of Lewy pathology: a critical update. J Neurol 2009; 256: 270-279
    CrossrefGoogle Scholar
  • 24 McKeith IG, Dickson DW, Lowe J et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872
    CrossrefGoogle Scholar
  • 25 Gore RL, Vardy ER, O’Brien JT. Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum?. J Neurol Neurosurg Psychiatry 2014; May 23. Epub ahead of print
    Google Scholar
  • 26 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab 2013; 33: 1696-1706
    CrossrefGoogle Scholar
  • 27 Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol 2012; 47: 816-824
    CrossrefGoogle Scholar
  • 28 Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-260
    CrossrefGoogle Scholar
  • 29 Beach TG, Monsell SE, Phillips LE et al. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J Neuropathol Exp Neurol 2012; 71: 266-273
    CrossrefPubMedGoogle Scholar
  • 30 Medicine WUSo Im Internet: http://knightadrc.wustl.edu/cdrtraining/browsebtrp/applicationstep1.htm
  • 31 Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis 2012; 29: 133-149
    Google Scholar
  • 32 Zetterberg H, Tullhog K, Hansson O et al. Low incidence of post-lumbar puncture headache in 1089 consecutive memory clinic patients. Eur Neurol 2010; 63: 326-330
    CrossrefGoogle Scholar
  • 33 Johnson KA, Minoshima S, Bohnen NI et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association. J Nucl Med 2013; 54: 476-490
    CrossrefGoogle Scholar
  • 34 Maier W, Barnikol UB. [Neurocognitive disorders in DSM-5: pervasive changes in the diagnostics of dementia]. Nervenarzt 2014; 85: 564-570
    CrossrefGoogle Scholar
  • 35 Mänz C, Reimold M, Bender B et al. Bildgebende Diagnostik der Alzheimer-Krankheit. Fortschr Röntgenstr 2012; 184: 1079-1082
    Article in Thieme ConnectGoogle Scholar
  • 36 Drzezga A. Amyloidplaque-Bildgebung in der Demenzdiagnostik. Der Nuklearmediziner 2009; 32: 170-177
    Article in Thieme ConnectGoogle Scholar